McClelland R - Search Results

1

Targeting focal adhesion kinase in ER+/HER2+ breast cancer improves trastuzumab response.

Lazaro G, Smith C, Goddard L, Jordan N, McClelland R, Barrett-Lee P, Nicholson RI, Hiscox S. Lazaro G, et al. Among authors: mcclelland r. Endocr Relat Cancer. 2013 Aug 28;20(5):691-704. doi: 10.1530/ERC-13-0019. Print 2013 Oct. Endocr Relat Cancer. 2013. PMID: 23900794

2

Inductive mechanisms limiting response to anti-epidermal growth factor receptor therapy.

Hutcheson IR, Knowlden JM, Jones HE, Burmi RS, McClelland RA, Barrow D, Gee JM, Nicholson RI. Hutcheson IR, et al. Among authors: mcclelland ra. Endocr Relat Cancer. 2006 Dec;13 Suppl 1:S89-97. doi: 10.1677/erc.1.01279. Endocr Relat Cancer. 2006. PMID: 17259562 Review.

3

Chronic exposure to fulvestrant promotes overexpression of the c-Met receptor in breast cancer cells: implications for tumour-stroma interactions.

Hiscox S, Jordan NJ, Jiang W, Harper M, McClelland R, Smith C, Nicholson RI. Hiscox S, et al. Among authors: mcclelland r. Endocr Relat Cancer. 2006 Dec;13(4):1085-99. doi: 10.1677/erc.1.01270. Endocr Relat Cancer. 2006. PMID: 17158755

4

Involvement of steroid hormone and growth factor cross-talk in endocrine response in breast cancer.

Nicholson RI, McClelland RA, Robertson JF, Gee JM. Nicholson RI, et al. Among authors: mcclelland ra. Endocr Relat Cancer. 1999 Sep;6(3):373-87. doi: 10.1677/erc.0.0060373. Endocr Relat Cancer. 1999. PMID: 10516852 Review.

5

Modulation of epidermal growth factor receptor in endocrine-resistant, oestrogen receptor-positive breast cancer.

Nicholson RI, Hutcheson IR, Harper ME, Knowlden JM, Barrow D, McClelland RA, Jones HE, Wakeling AE, Gee JM. Nicholson RI, et al. Among authors: mcclelland ra. Endocr Relat Cancer. 2001 Sep;8(3):175-82. doi: 10.1677/erc.0.0080175. Endocr Relat Cancer. 2001. PMID: 11566608 Review.

6

Deciphering antihormone-induced compensatory mechanisms in breast cancer and their therapeutic implications.

Gee JM, Shaw VE, Hiscox SE, McClelland RA, Rushmere NK, Nicholson RI. Gee JM, et al. Among authors: mcclelland ra. Endocr Relat Cancer. 2006 Dec;13 Suppl 1:S77-88. doi: 10.1677/erc.1.01274. Endocr Relat Cancer. 2006. PMID: 17259561 Review.

7

Fulvestrant-induced expression of ErbB3 and ErbB4 receptors sensitizes oestrogen receptor-positive breast cancer cells to heregulin β1.

Hutcheson IR, Goddard L, Barrow D, McClelland RA, Francies HE, Knowlden JM, Nicholson RI, Gee JM. Hutcheson IR, et al. Among authors: mcclelland ra. Breast Cancer Res. 2011 Mar 11;13(2):R29. doi: 10.1186/bcr2848. Breast Cancer Res. 2011. PMID: 21396094 Free PMC article.

8

Tamoxifen-induced epigenetic silencing of oestrogen-regulated genes in anti-hormone resistant breast cancer.

Stone A, Valdés-Mora F, Gee JM, Farrow L, McClelland RA, Fiegl H, Dutkowski C, McCloy RA, Sutherland RL, Musgrove EA, Nicholson RI. Stone A, et al. PLoS One. 2012;7(7):e40466. doi: 10.1371/journal.pone.0040466. Epub 2012 Jul 10. PLoS One. 2012. PMID: 22808167 Free PMC article.

9

The biology of antihormone failure in breast cancer.

Nicholson RI, Gee JM, Knowlden J, McClelland R, Madden TA, Barrow D, Hutcheson I. Nicholson RI, et al. Among authors: mcclelland r. Breast Cancer Res Treat. 2003;80 Suppl 1:S29-34; discussion S35. doi: 10.1023/a:1025467500433. Breast Cancer Res Treat. 2003. PMID: 14535532 Review.

10

Dual immunocytochemical analysis of oestrogen and epidermal growth factor receptors in human breast cancer.

Sharma AK, Horgan K, Douglas-Jones A, McClelland R, Gee J, Nicholson R. Sharma AK, et al. Among authors: mcclelland r. Br J Cancer. 1994 Jun;69(6):1032-7. doi: 10.1038/bjc.1994.203. Br J Cancer. 1994. PMID: 8198966 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

881 results

Search Page

Filters